In May, 2016, Allison Wey was appointed Vice President, Investor Relations and Corporate Communications for Regulus Therapeutics. Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations, and investment banking. Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey also worked in media relations and corporate communications leadership roles including VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc.